DiaMedica gets SAHPRA approval for Phase II preeclampsia treatment trial
The open-label, single-centre, single-arm trial will assess the safety and pharmacodynamics of DM199 in treating preeclampsia.
Cassava Sciences: Phase III trials storm ahead amid controversy
GSK reports positive findings from Phase III RSV vaccine trial
Allurion’s swallowable balloon hits trial success amid weakening financials
KaliVir doses first subject in Phase I/Ib solid tumour treatment trial
Purespring secures $105m to start Phase I/II trial of IgAN gene therapy
MSD’s Phase III trial of head and neck cancer treatment meets primary endpoint
Gilead reports updated data from trial of acclaimed HIV PrEP drug
Analysis
View More
Themes
View MoreNIH selects Emergex’s T cell vaccine for trials under Project NextGen
As part of the development, NIAID is expected to cover the entire cost of the Phase I clinical trial.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Exscientia outline robot and AI use in drug discovery workflow
Perimeter completes enrolment for AI-assisted breast imaging trial
Microbot shifts pivotal trial up a gear with completion expected ahead of schedule
Moderna blamed after children offered £1,500 to take part in Covid-19 trial